Legend Biotech Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN), based in Somerset, NJ, has announced its participation in two upcoming investor conferences. The first is the Cowen 43rd Annual Healthcare Conference in Boston, MA on March 7, 2023, at 9:50 AM ET, featuring CEO Ying Huang, Ph.D. The second event is the Barclays Global Healthcare Conference in Miami, FL on March 14, 2023, at 10:15 AM ET, also presented by Dr. Huang. Legend Biotech focuses on developing novel therapies for life-threatening diseases through advanced cell therapies.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:

Event: Cowen 43^rd Annual Healthcare Conference
Location: Boston, MA
Fireside Chat Date & Time: Tuesday, March 7, 2023 at 9:50am ET
Presenter: Ying Huang, Ph.D., CEO

Event: Barclays Global Healthcare Conference
Location: Miami, FL
Fireside Chat Date & Time: Tuesday, March 14, 2023 at 10:15am ET
Presenter: Ying Huang, Ph.D., CEO

About Legend Biotech
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230224005077/en/

Press Contact:

Tina Carter, Corporate Communications Lead, Legend Biotech

tina.carter@legendbiotech.com

(908) 331-5025

Investor Contacts:

Joanne Choi, Senior Manager, Investor Relations, Legend Biotech

joanne.choi@legendbiotech.com

Crystal Chen, Manager, Investor Relations, Legend Biotech

crystal.chen@legendbiotech.com

Source: Legend Biotech

FAQ

What upcoming conferences will Legend Biotech participate in?

Legend Biotech will participate in the Cowen 43rd Annual Healthcare Conference in Boston on March 7, 2023, and the Barclays Global Healthcare Conference in Miami on March 14, 2023.

Who is presenting for Legend Biotech at the investor conferences?

Ying Huang, Ph.D., CEO of Legend Biotech, will present at both conferences.

When is Legend Biotech's fireside chat at the Cowen Conference?

The fireside chat at the Cowen Conference is scheduled for March 7, 2023, at 9:50 AM ET.

What is the date and time for Legend Biotech's presentation at the Barclays Conference?

Legend Biotech's presentation at the Barclays Conference is on March 14, 2023, at 10:15 AM ET.